In December, President Donald Trump in an executive order told his attorney general to expediate a rulemaking process related to rescheduling marijuana as a less-dangerous drug.

Pot stocks Trulieve Cannabis, Curaleaf, Cresco Labs, Green Thumb Industries, and Canopy Growth plummeted by up to 39% due to the scope of Trump's intentions. However, there's a silver lining for ...

Cannabis stocks remain under pressure after President Donald Trump signed an executive order Thursday directing the Department of Justice to reschedule marijuana as a lower-class drug. The Department ...

Cannabis investors may be feeling bullish entering 2026 after marijuana rescheduling, but some more advances are needed for ...

The Department of Justice’s push to reclassify marijuana as a Schedule III drug Thursday provided an immediate jolt on Wall Street for a group of publicly traded cannabis companies, as the Biden ...

We recently compiled a list of the 10 Best Marijuana Stocks To Buy According to Hedge Funds. In this article, we are going to take a look at where Tilray Brands, Inc. (NASDAQ:TLRY) stands against the ...

Cannabis stocks jump as Trump signs executive order to reclassify marijuana, easing federal rules and boosting investment potential.

Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.

The DEA recommended loosening regulations on marijuana yesterday. As a Schedule III drug, marijuana would still be regulated and some costs would rise for cannabis companies -- but others would fall.

President Donald Trump on Thursday signed an executive order asking the U.S. government to reschedule cannabis, a move that marks the most significant federal reform on the substance in decades, ...

A decade from now, investors may very well look back and proclaim the cannabis industry to be the greatest growth opportunity of our generation. We know the demand is there given the tens of billions ...